14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NWRN.SW
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Newron Pharmaceuticals S.p.A. stock price ended at 6.69 Fr on Thursday, after losing 4.43%.
(Updated on Apr 25, 2024)

Sell candidate since Apr 08, 2024 Loss -13.00% PDF

The Newron Pharmaceuticals S.p.A. stock price fell by -4.43% on the last day (Thursday, 25th Apr 2024) from 7.00 Fr to 6.69 Fr. During the last trading day the stock fluctuated 6.29% from a day low at 6.52 Fr to a day high of 6.93 Fr. The price has fallen in 5 of the last 10 days and is down by -8.98% for this period. Volume has increased on the last day by 20 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 63 thousand shares were bought and sold for approximately 424.57 Fr thousand.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at 6.58 Fr is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -13.65% during the next 3 months and, with a 90% probability hold a price between 5.68 Fr and 7.04 Fr at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NWRN.SW Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 0.150%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Newron Pharmaceuticals S.p.A. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at 6.96 Fr and 7.60 Fr. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Newron Pharmaceuticals S.p.A. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Newron Pharmaceuticals S.p.A. stock

Newron Pharmaceuticals S.p.A. finds support from accumulated volume at 6.68 Fr and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved 0.410 Fr between high and low, or 6.29%. For the last week, the stock has had daily average volatility of 6.97%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NWRN.SW) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Newron Pharmaceuticals S.p.A. to open at 6.71 Fr, and during the day (based on 14 day Average True Range), to move between 6.18 Fr and 7.20 Fr, which gives a possible trading interval of +/-0.514 Fr (+/-7.68%) up or down from last closing price. If Newron Pharmaceuticals S.p.A. takes out the full calculated possible swing range there will be an estimated 15.35% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at 6.68 Fr (0.15%) than the resistance at 6.95 Fr (3.89%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Newron Pharmaceuticals S.p.A. stock A Buy?

Newron Pharmaceuticals S.p.A. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.906 Sell Candidate Unchanged

Predicted Opening Price for Newron Pharmaceuticals S.p.A. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
6.71 Fr ( 0.349%) 6.69 Fr

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NWRN.SW

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 7.12 6.48 %
R2 6.97 4.14 %
R1 6.87 2.69 %
Current price: 6.69
Support S1 6.56 -1.99 %
S2 6.46 -3.44 %
S3 6.30 -5.78 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 7.84 17.19 %
R2 7.82 16.89 %
R1 6.95 3.89 %
Current price 6.69
Support S1 6.68 -0.149%
S2 0 .
S3 0 .

FAQ

What is the symbol for Newron Pharmaceuticals S.p.A. Stock and on which exchange is it traded?
The symbol for Newron Pharmaceuticals S.p.A. is NWRN.SW and it is traded on the SIX (SIX Swiss Exchange).

Should I buy or sell Newron Pharmaceuticals S.p.A. Stock?
Newron Pharmaceuticals S.p.A. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Newron Pharmaceuticals S.p.A. Stock?
Newron Pharmaceuticals S.p.A. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Newron Pharmaceuticals S.p.A. Stock.

What's the current price of Newron Pharmaceuticals S.p.A. Stock?
As of the end of day on the Apr 25, 2024, the price of an Newron Pharmaceuticals S.p.A. (NWRN.SW) share was 6.69 Fr.

What is the 52-week high and low for Newron Pharmaceuticals S.p.A. Stock?
The 52-week high for Newron Pharmaceuticals S.p.A. Stock is 11.45 Fr and the 52-week low is 3.70 Fr.

What is the market capitalization of Newron Pharmaceuticals S.p.A. Stock?
As of the Apr 25, 2024, the market capitalization of Newron Pharmaceuticals S.p.A. is 124.647M.

When is the next earnings date for Newron Pharmaceuticals S.p.A.?
The upcoming earnings date for Newron Pharmaceuticals S.p.A. is Sep 19, 2024.
Click to get the best stock tips daily for free!

About Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resi... NWRN.SW Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT